Serial 98976882
Live / Registered — Registered (as of 18 Nov 2025)
What this means for you
Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98976882
- Registration number
- 8034780
- Mark type
- Design / logo
- Filed
- 12 Jan 2024
- Published for opposition
- 04 Mar 2025
- Registered
- 18 Nov 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
- Class 042 — Scientific and technological services: Providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia
- Class 044 — Medical, beauty and agricultural services: Providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Aug 2025 — USE AMENDMENT FILED
- 23 Oct 2025 — DIVISIONAL PROCESSING COMPLETE
- 21 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 23 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 21 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED